First UK trial of AIDS vaccine approved.
Concar
D
D
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000517:prevention & control; D004341:Drug Evaluation; D015683:Gene Products, gag / Q000009:adverse effects*; D015483:HIV Antibodies / Q000032:analysis; D016655:HIV Core Protein p24; D006679:HIV Seropositivity; D006801:Humans; D006113:United Kingdom; D014758:Viral Core Proteins / Q000009:adverse effects*; D014765:Viral Vaccines / Q000009:adverse effects*
D016915:AIDS Vaccines; D015683:Gene Products, gag; D015483:HIV Antibodies; D016655:HIV Core Protein p24; D014758:Viral Core Proteins; D014765:Viral Vaccines; C065031:p24-VLP vaccine